Division of Hematology/Oncology


faculty photo

Ronac Mamtani, MD, MSCE

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Attending Physician, Hematology-Oncology, Philadelphia Veterans Affairs Medical Center
Attending Physician, Hematology-Oncology, Hospital of the University of Pennsylvania
Instructor A in Medicine, University of Pennsylvania
Department: Medicine

Contact information
16 Penn Tower
3400 Spruce Street
Philadelphia, PA 19147
Office: 215-265-3040
Cornell University, 2002.
MD (Internal Medicine)
Stony Brook School of Medicine, 2006.
MS (Clinical Epidemiology)
University of Pennsylvania , 2012.
Post-Graduate Training
Intern in Medicine, NY Hospital-Cornell Medical College, 2006-2007.
Resident in Medicine, NY Hospital-Cornell Medical College, 2007-2009.
Assistant Chief Resident in Medicine, NY Hospital-Cornell Medical College, 2008-2009.
Fellow in Hematology-Oncology, Hospital of the University of Pennsylvania, 2009-2012.
American Board of Internal Medicine, 2009.
American Board of Internal Medicine (Medical Oncology), 2012.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Lewis JD, Habel L, Quesenberry C, Mamtani R, Peng T, Bilker W, Hedderson M, Nissel L, Vaughn DJ, Strom BL, Ferrara A: Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiology and Drug Safety 23(6): 636-45, 2014.

Mamtani R, Finkelman BS, Haynes K, Scott FI, Lewis JD: Distinguishing Incident and Prevalent Diabetes in an Electronic Medical Record Database. Pharmacoepidemiology Drug Safety 23(2), 2014.

Boursi B, Haynes K, Mamtani R, Yang YX.: Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol 2014.

Scott FI, Vajravelu RK, Bewtra M, Mamtani R, Lee D, Goldberg DS, Lewis JD.: The Benefit-to-Risk Balance of Combining Infliximab With Azathioprine Varies With Age: A Markov Model. Clin Gastroenterol Hepatol 2014.

Boursi B, Haynes K, Mamtani R, Yang YX.: Digoxin use and the risk for colorectal cancer. Pharmacoepidemiol Drug Saf 2014.

Datta J, Lewis RS Jr, Mamtani R, Stripp D, Kelz RR, Drebin JA, Fraker DL, Karakousis GC, Roses RE.: Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base. Cancer 120(18), 2014.

Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD.: Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. Diabetes Care 2014.

James D Lewis, Brian L Strom, Laurel Habel, Tiffany Peng, Monique Hedderson, Warren Bilker, Charles Quesenberry, Ronac Mamtani, Lisa Nessel, David Vaughn, Assiamira Ferrara.: Relative Risk of Bladder Cancer with Pioglitazone for Diabetes Mellitus: An Updated 8-Year Interim Report of a 10-Year Follow-Up Study. International Society for Pharmacoepidemiology 2013 Notes: Oral Presentation, Montreal.

Mamtani, R, Haynes, K, Bilker, WB, Vaughn, DJ, Strom, BL, Glanz, K, Lewis, JD: Long-Term Therapy with Thiazolidinediones May Be Associated with Increased Incidence of Bladder Cancer. Pharmacoepidemiology And Drug Safety 21(3): 25, 2012 Notes: Oral Abstract Presentation, International Society for Pharmacoepidemiology, Barcelona, 2012.

Jeurkar, N, Mamtani, R, Vaughn, DJ: Granulomatosis and Testicular Germ Cell Tumors. Urology 80(6): 1303-1306, 2012.

back to top
Last updated: 10/24/2014
The Trustees of the University of Pennsylvania

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter